AGP Picks
View all

Michigan Technology Journal
Provided by AGP

Michigan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

November 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30

Press releases published on November 2, 2026

Disc Medicine to Participate in Upcoming Investor Conferences
Nov. 2, 2026

Disc Medicine to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
Nov. 2, 2026

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Indeterminate GlobeNewswire
Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting
Nov. 2, 2026

Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting

Indeterminate GlobeNewswire
IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026
Nov. 2, 2026

IMUNON to Hold Third Quarter 2026 Financial Results and Business Update Conference Call on Thursday, November 12, 2026

Indeterminate GlobeNewswire
Humanoid Global Highlights Portfolio Company Formic’s US$50 Million Raise, Led by Mercato Partners, to Advance Physical AI Across American Manufacturing
Nov. 2, 2026

Humanoid Global Highlights Portfolio Company Formic’s US$50 Million Raise, Led by Mercato Partners, to Advance Physical AI Across American Manufacturing

Indeterminate GlobeNewswire
Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer
Nov. 2, 2026

Propanc Biopharma Reports Preclinical Data with PRP & PRP plus TGF-β Inhibitor on TGF-β Pathway in Pancreatic Cancer

Indeterminate GlobeNewswire
Trust Stamp announces presentation on Company’s progress and 2027 Business Plan
Nov. 2, 2026

Trust Stamp announces presentation on Company’s progress and 2027 Business Plan

Indeterminate GlobeNewswire
Micware Expands North American Presence with Relocation of U.S. Office in Dublin, Ohio
Nov. 2, 2026

Micware Expands North American Presence with Relocation of U.S. Office in Dublin, Ohio

Indeterminate GlobeNewswire
Leonardo DRS Selected by AV for U.S. Army’s Enduring-High Energy Laser Production Program
Nov. 2, 2026

Leonardo DRS Selected by AV for U.S. Army’s Enduring-High Energy Laser Production Program

Indeterminate GlobeNewswire
Inuvo’s IntentKey Puts Custom Audiences Live on Safari and iPhone Within 24 Hours
Nov. 2, 2026

Inuvo’s IntentKey Puts Custom Audiences Live on Safari and iPhone Within 24 Hours

Indeterminate GlobeNewswire
BacBit Unveils Next-Generation AI-Driven Digital Asset Trading Ecosystem
Nov. 2, 2026

BacBit Unveils Next-Generation AI-Driven Digital Asset Trading Ecosystem

Indeterminate GlobeNewswire
NowVertical Announces Release of Units from Escrow to Teraz Fund
Nov. 2, 2026

NowVertical Announces Release of Units from Escrow to Teraz Fund

Indeterminate GlobeNewswire
Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach
Nov. 2, 2026

Asure Software and Vertex Announce Strategic Alliance to Expand Payroll Tax Management Reach

Indeterminate GlobeNewswire
A3P Biomedical appoints Matt Franklin as President, North America to accelerate US market access for Stockholm3
Nov. 2, 2026

A3P Biomedical appoints Matt Franklin as President, North America to accelerate US market access for Stockholm3

Indeterminate GlobeNewswire
Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis
Nov. 2, 2026

Teva to Discontinue Phase 2 TOPAS-MSA Study of emrusolmin (TEV-‘286) Following Interim Futility Analysis

Indeterminate GlobeNewswire
CytomX Therapeutics to Present at Upcoming November Investor Conferences
Nov. 2, 2026

CytomX Therapeutics to Present at Upcoming November Investor Conferences

Indeterminate GlobeNewswire
New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud
Nov. 2, 2026

New SEON Survey Finds U.S. Consumers Are Embracing AI Agents, but 65% Would Blame the AI Company if One Commits Fraud

Indeterminate GlobeNewswire
Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences
Nov. 2, 2026

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

Indeterminate GlobeNewswire
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026
Nov. 2, 2026

Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026

Indeterminate GlobeNewswire
Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov. 2, 2026

Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Michigan Technology Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.